NCT05505487

Brief Summary

  1. 1.To understand the occurrence of pulmonary infection in stroke patients with tracheotomy, and to clarify the current situation of clinical nursing.
  2. 2.Construct a standardized, systematic and scientific integrated care model to control the severity of pulmonary infection in non-acute stroke patients with simple tracheotomy.
  3. 3.To evaluate the clinical application effect of integrated care model of pulmonary infection in stroke patients with tracheotomy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 7, 2022

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 14, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 17, 2022

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2026

Completed
Last Updated

August 17, 2022

Status Verified

May 1, 2022

Enrollment Period

4 years

First QC Date

May 14, 2022

Last Update Submit

August 15, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinical Pulmonary Infection Score

    The scale mainly includes 7 indicators of body temperature, white blood cell count, tracheal secretions, oxygenation, chest X-ray, progress of pulmonary exudation, and microbial culture of tracheal aspirates, each with 0 to 2 points, with a total score of 12 If the score is less than 6, the lung infection is considered to be controlled.

    Within 1 week of admission

  • Clinical Pulmonary Infection Score

    The scale mainly includes 7 indicators of body temperature, white blood cell count, tracheal secretions, oxygenation, chest X-ray, progress of pulmonary exudation, and microbial culture of tracheal aspirates, each with 0 to 2 points, with a total score of 12 If the score is less than 6, the lung infection is considered to be controlled.

    3 weeks after admission

Secondary Outcomes (6)

  • Beck Oral Assessment Score(BOAS),modified

    Within 1 week of admission

  • Beck Oral Assessment Score(BOAS),modified

    3 weeks after admission

  • Zarit Caregiver Burden Interview, ZBI

    Within 1 week of admission

  • Zarit Caregiver Burden Interview, ZBI

    3 weeks after admission

  • EuroQol-5 Dimension, EQ-5D

    Within 1 week of admission

  • +1 more secondary outcomes

Other Outcomes (1)

  • hospital costs

    ≥3 weeks

Study Arms (2)

control group

NO INTERVENTION

Implement routine nursing such as: routine oral nursing, tracheostomy, dressing change, sputum suction nursing, oral education, etc.

intervention group

EXPERIMENTAL

Implement comprehensive nursing models such as: admission risk assessment, personalized oral care based on beck oral score, aspiration prevention, airway care, diversified health education

Other: integrated care model

Interventions

The interventions in this study were to implement basic patient care only and did not involve any invasive procedures. On the basis of routine nursing, the content of nursing intervention was integrated, and a standardized nursing model was formed for clinical application to control the severity of pulmonary infection in patients with simple tracheotomy in the non-acute phase of stroke.

intervention group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-acute stroke patients diagnosed by MRI or CT who meet the diagnostic criteria of the "Chinese Guidelines for the Prevention and Treatment of Cerebrovascular Diseases";
  • Those who meet the diagnostic criteria for pulmonary infection;
  • Age ≥18 years old;
  • Tracheotomy patients who have been off the ventilator or do not need mechanical ventilation;
  • Patients who can cooperate with the research and sign the informed consent.

You may not qualify if:

  • Patients whose vital signs are unstable and may be transferred to ICU for treatment in the future;
  • Patients with malignant tumors or other infectious diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second People's Hospital of Shenzhen

Shenzhen, Guangdong, 518035, China

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Yan Gao, Ph.D

    Shenzhen Second People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study is a quasi-experimental study; no equal control design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2022

First Posted

August 17, 2022

Study Start

May 7, 2022

Primary Completion

May 7, 2026

Study Completion

May 7, 2026

Last Updated

August 17, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Contact the principal investigator for data if necessary

Locations